CYPHCYPHERPUNK TECHNOLOGIES INC.同业对比
CYPHERPUNK TECHNOLOGIES INC. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CYPH本股 | $277M#9 | 4.0x#3 | 2.0x#8 | 185.0x#6 | 0.0%#2 | 107.4%#2 | -2737.8%#7 | 3.6%#2 | — | — | 520.3%#1 | — |
| ENTA | $312M#1 | — | 3.1x#11 | 4.8x#3 | -3.4%#3 | 29.4%#3 | -130.7%#3 | -81.0%#10 | — | — | -0.9%#6 | — |
| VOGX | $307M#2 | — | — | — | — | — | — | — | — | — | — | — |
| SPRY | $300M#3 | — | 24.0x#12 | 3.6x#2 | -5.5%#4 | -2241.8%#15 | -212.9%#4 | -1369.1%#15 | -177.6%#2 | — | -65.0%#15 | — |
| BNTC | $296M#4 | — | 1.7x#7 | — | -100.0%#7 | -20.6%#9 | — | -25.8%#5 | — | — | -46.6%#11 | — |
| MPLT | $293M#6 | 0.1x#1 | 0.8x#3 | — | — | -107.7%#13 | — | -46.3%#8 | — | — | -58.6%#14 | — |
| TTRX | $295M#5 | — | 430.2x#14 | — | — | -80.6%#11 | — | -465.0%#13 | — | — | 122.7%#3 | — |
| FULC | $286M#7 | — | 0.9x#4 | — | -100.0%#7 | -670.0%#14 | — | -24.1%#4 | — | — | -58.4%#13 | — |
| RCKT | $275M#10 | — | 0.7x#2 | — | — | 13.8%#6 | — | -60.5%#9 | — | — | -29.6%#8 | — |
| ARCT | $268M#11 | — | 1.6x#6 | 3.3x#1 | -46.1%#6 | 18.7%#5 | -93.0%#2 | -38.3%#6 | -136.2%#1 | — | 1.5%#5 | — |
| LYEL | $279M#8 | — | 1.2x#5 | 7742.9x#7 | -41.0%#5 | 20.0%#4 | -748344.4%#8 | -117.4%#11 | — | — | -30.6%#9 | — |
| QTTB | $264M#13 | 2.8x#2 | 2.5x#10 | 4.9x#4 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | 244.9%#2 | — |
| BIOA | $264M#12 | — | 0.7x#1 | 29.4x#5 | — | -13.4%#8 | -1031.5%#6 | -21.5%#3 | — | — | -22.4%#7 | — |
| LRMR | $258M#14 | — | 2.0x#9 | — | — | -105.5%#12 | — | -130.1%#12 | -350.3%#3 | — | -36.2%#10 | — |
| BCYC | — | — | — | — | 105.8%#1 | -29.5%#10 | -340.4%#5 | -43.3%#7 | -372.9%#4 | — | -49.9%#12 | — |
| GLSI | $253M#15 | — | 81.0x#13 | — | — | -11.2%#7 | — | -621.1%#14 | — | — | 102.5%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议